Evidence map›Paper›PMID 32082479›Full record

ReviewOxidative medicine and cellular longevity2020

Oxidative Stress in the Pathophysiology of Kidney Disease: Implications for Noninvasive Monitoring and Identification of Biomarkers.

Marianna Gyurászová, Radana Gurecká, Janka Bábíčková, Ľubomíra Tóthová

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06650384 (Evaluation of the Efficacy and Safety of N-Acetylcysteine Versus Alpha-Lipoic Acid on the Occurrence and Severity of Colistin-Induced Nephrotoxicity in Critically Ill Patients), which is not on this map. Cited by 167 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
167citing papers in PubMed, 3 pooled it
20.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06650384 phase2 / phase3completednot on this mapstarted 2024, after this paper: background citation

Evaluation of the Efficacy and Safety of N-Acetylcysteine Versus Alpha-Lipoic Acid on the Occurrence and Severity of Colistin-Induced Nephrotoxicity in Critically Ill Patients

TypeinterventionalSponsorAin Shams UniversityRan2024 to 2026Enrolled180ConditionsNephrotoxicityArmsAddition of sachets of N-acetyl cysteine 1200 mg twice/day to the maintenance dose of colistin, Addition of Alpha-lipoic acid 600mg twice daily to the maintenance dose of colistin
3 · Its place in the literature

Who cites it

167 citing papers in PubMed, 3 syntheses or guidelines pooled it, 298 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Features of Lipid Disorders in Cardiovascular-Kidney-Metabolic Syndrome.International journal of molecular sciences · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

107 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Marianna GyurászováInstitute of Molecular Biomedicine, Faculty of Medicine in Bratislava, Comenius University, Bratislava, Slovakia.ORCID https://orcid.org/0000-0002-7921-5690
Radana GureckáInstitute of Medical Physics, Biophysics, Informatics and Telemedicine, Faculty of Medicine in Bratislava, Comenius University, Bratislava, Slovakia.ORCID https://orcid.org/0000-0002-5880-666X
Janka BábíčkováInstitute of Molecular Biomedicine, Faculty of Medicine in Bratislava, Comenius University, Bratislava, Slovakia.ORCID https://orcid.org/0000-0001-7859-9242
Ľubomíra TóthováInstitute of Molecular Biomedicine, Faculty of Medicine in Bratislava, Comenius University, Bratislava, Slovakia.ORCID https://orcid.org/0000-0001-9162-4916
Comenius University Bratislava · SKUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney disease represents a serious global health problem. One of the main concerns is its late diagnosis, only feasible in a progressed disease state. The lack of a clinical manifestation in the early stages and the fact that the commonly measured parameters of renal function are markedly reduced only during advanced stages of the disease are the main cause. Changes at the molecular level of the kidney tissue occur even before nitrogenous substances, such as creatinine and urea, start to accumulate in the blood. Renal proximal tubules contain a large number of mitochondria and are critical for the energy-demanding process of reabsorption of water and solutes. Mitochondria are the largest producers of oxygen radicals, which, in turn, increase the susceptibility of kidneys to oxidative stress-induced damage. Free radicals and prooxidants produced during acute or chronic kidney injury may further aggravate the course of the disease and play a role in the pathogenesis of subsequent complications. Prevention might be the solution in CKD, but patients are often reluctant to undergo preventive examinations. Noninvasive markers and the possibility to obtain samples at home might help to increase compliance. This review will provide an overview of the possible uses of markers of oxidative status in noninvasive biofluids in patients with renal disease.

Indexed as

Oxidative StressAcute Kidney InjuryAnimalsBiomarkersCytokinesGlutathioneHumansInflammationKidney Tubules, ProximalMitochondriaReactive Oxygen SpeciesRenal Insufficiency, ChronicUreaBiomarkersCytokinesGlutathioneReactive Oxygen SpeciesUrea

Identifiers

PMID32082479
PMCPMC7007944
OpenAlexW3003972077

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.